Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Justin T Matulay"'
Autor:
Jason Zhu, Chad Livasy, Erin E. Donahue, James T. Symanowski, Claud M. Grigg, Landon C. Brown, Justin T. Matulay, James T. Kearns, Derek Raghavan, Earle F. Burgess, Peter E. Clark
Publikováno v:
Translational Andrology and Urology. 12:228-240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8c09e835ebc0295cb6909b44431e0f
https://doi.org/10.21037/tau-22-494
https://doi.org/10.21037/tau-22-494
Autor:
Amy H. Lim, Mary E. Westerman, Andrea Korokovic, Justin T. Matulay, Vikram M. Narayan, Neema Navai
Publikováno v:
Bladder Cancer. 8:193-209
BACKGROUND: The benefit of surgery of the primary tumor in metastatic bladder cancer is unknown. OBJECTIVE: Perform a comprehensive contemporary literature review on the benefit of surgery of the primary tumor in metastatic bladder cancer. METHODS: O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce8132155c172825a1afa85bb96a806b
https://doi.org/10.3233/blc-211529
https://doi.org/10.3233/blc-211529
Autor:
Colin P.N. Dinney, Neema Navai, Ashish M. Kamat, Patrick J. Hensley, Justin T. Matulay, Nathan A. Brooks, Graciela M. Nogueras-Gonzalez, Kelly K. Bree, Supriya Nagaraju, H. Barton Grossman, Roger Li
Publikováno v:
Eur Urol Oncol
Background Guideline indications for restaging transurethral resection (reTUR) for high-grade (HG) Ta bladder tumors vary due to a paucity of data. Objective To investigate guideline-based, risk-adapted approaches to reTUR for HG Ta lesions. Design,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6aad8ed8b7353c888a55e8b4244b10
https://doi.org/10.1016/j.euo.2021.04.003
https://doi.org/10.1016/j.euo.2021.04.003
Autor:
Siamak Daneshmand, Michiel S van der Heijden, Joseph M Jacob, Andrea Necchi, Evanguelos Xylinas, David S Morris, Philip Spiegelhalder, Daniel Zainfeld, Taek Won Kang, Justin T Matulay, Laurence H Belkoff, Karel Decaestecker, Harm Arentsen, Shalaka Hampras, Shu Jin, Christopher J Cutie, Hussein Sweiti, Katherine Stromberg, Jason Martin, Giuseppe Simone
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0382fbc417d84b5e61f355388fa86736
https://doi.org/10.1097/ju.0000000000003361.03
https://doi.org/10.1097/ju.0000000000003361.03
Autor:
Emily, Roebuck, Wei, Sha, Caroline D, Lu, Caroline, Miller, Earle F, Burgess, Claud M, Grigg, Jason, Zhu, Kris E, Gaston, Stephen B, Riggs, Justin T, Matulay, Peter E, Clark, James T, Kearns
Publikováno v:
Urology. 163:156-163
To evaluate whether racial disparities in MRI-Bx usage persisted after correction for socioeconomic, demographic, and clinical factors.This is a retrospective cohort study of patients who received either MRI-Bx or systematic biopsy (SB) within a sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30438caa9e33321969ca0f1a585284eb
https://doi.org/10.1016/j.urology.2021.11.040
https://doi.org/10.1016/j.urology.2021.11.040
Autor:
Ashish M. Kamat, Niyati Lobo, Seth P. Lerner, Roger Li, Justin T. Matulay, Joan Palou, J. Alfred Witjes, Morgan Rouprêt, Angela B. Smith, Sam S. Chang, Neal D. Shore, Gary D. Steinberg, Colin P. Dinney, Robert S. Svatek, Donald L. Lamm
Publikováno v:
Bladder Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Bladder Cancer, 8, 113-117
Bladder Cancer, 8, 2, pp. 113-117
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Bladder Cancer, 8, 113-117
Bladder Cancer, 8, 2, pp. 113-117
When it comes to the treatment of patients with non-muscle-invasive bladder cancer (NMIBC) with intravesical bacillus Calmette-Guérin (BCG), two questions must be considered: 1) what dose to give, and 2) for how long? The issue of optimal dose and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc0d53f780f1012774120cf3d4046e1
https://doi.org/10.3233/blc-211648
https://doi.org/10.3233/blc-211648
Autor:
Justin T. Matulay, Ashish M. Kamat
Publikováno v:
F1000Research, Vol 7 (2018)
Bladder cancer is a heterogeneous disease that poses unique challenges to the treating clinician. It can be limited to a relatively indolent papillary tumor with low potential for progression beyond this stage to muscle-invasive disease prone to dist
Externí odkaz:
https://doaj.org/article/19d7e6b6041e4bf49008dd6ec956b382
Autor:
James T. Kearns, Jason Zhu, Stephen B. Riggs, Kris E. Gaston, Timothy Hetherington, Claud Grigg, Earle F. Burgess, William E. Anderson, Justin T. Matulay, Peter E. Clark
Publikováno v:
Urology Practice. 8:619-623
Introduction:5-Alpha reductase inhibitor (5-ARI) use leads to a 50% decline in serum prostate specific antigen (PSA) without a concomitant decrease in prostate cancer (PCa) risk. We hypothe...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8df786099986a96516d235e848fe9ce8
https://doi.org/10.1097/upj.0000000000000257
https://doi.org/10.1097/upj.0000000000000257
Autor:
R. Tucker Burks, Cory Brouwer, Justin T. Matulay, Connor Frasier, Aaron Hartman, David M. Foureau, James T. Kearns, Earle F. Burgess, Stephen B. Riggs, Peter E. Clark, Jason Zhu, Claud Grigg, Nury Steuerwald, J. Alexa Sanders, Kris E. Gaston
Publikováno v:
Transl Androl Urol
Background Intravesical bacillus Calmette-Guerin (BCG) therapy is standard treatment for high-risk non-muscle invasive bladder cancer (NMIBC) but overall efficacy is low, and no reliable predictive biomarkers currently exist to refine patient selecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::918105d8e3da4b9dc90ca6be616ce60e
https://doi.org/10.21037/tau-21-158
https://doi.org/10.21037/tau-21-158
Autor:
Neema Navai, Nathan A. Brooks, Colin P.N. Dinney, Justin T. Matulay, Patrick J. Hensley, Ashish M. Kamat, Kelly K. Bree, Graciela M. Nogueras González, Roger Li, Surena F. Matin, H. B. Grossman
Publikováno v:
BJU International. 128:568-574
OBJECTIVE To evaluate the impact of upper tract urothelial carcinoma (UTUC) on bacillus Calmette-Guerin (BCG) response and progression in patients with non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS We performed an institutional rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea88e6b96f9352b4abccc80f0e4d8586
https://doi.org/10.1111/bju.15344
https://doi.org/10.1111/bju.15344